Manuel Campos-Toimil
Overview
Explore the profile of Manuel Campos-Toimil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morana-Fernandez S, Vazquez-Abuin X, Aragon-Herrera A, Anido-Varela L, Garcia-Seara J, Otero-Garcia O, et al.
Biochem Pharmacol
. 2024 Oct;
230(Pt 1):116571.
PMID: 39424202
The promising results obtained in the PARADIGM-HF trial prompted the approval of sacubitril/valsartan (SAC/VAL) as a first-in-class treatment for heart failure with reduced ejection fraction (HFrEF) patients. The effect of...
2.
Seoane N, Picos A, Morana-Fernandez S, Schmidt M, Dolga A, Campos-Toimil M, et al.
Cells
. 2024 May;
13(10.
PMID: 38786065
In various neurodegenerative conditions, inflammation plays a significant role in disrupting the blood-brain barrier (BBB), contributing to disease progression. Nitric oxide (NO) emerges as a central regulator of vascular function,...
3.
Bandin-Vilar E, Garcia-Quintanilla L, Castro-Balado A, Zarra-Ferro I, Gonzalez-Barcia M, Campos-Toimil M, et al.
Clin Pharmacokinet
. 2023 Aug;
62(9):1331.
PMID: 37535241
No abstract available.
4.
Shevchuk O, Palii S, Pak A, Chantada N, Seoane N, Korda M, et al.
Cells
. 2023 May;
12(9).
PMID: 37174696
Coronavirus disease (COVID-19) causes various vascular and blood-related reactions, including exacerbated responses. The role of endothelial cells in this acute response is remarkable and may remain important beyond the acute...
5.
Aragon-Herrera A, Morana-Fernandez S, Otero-Santiago M, Anido-Varela L, Campos-Toimil M, Garcia-Seara J, et al.
Biomed Pharmacother
. 2023 Mar;
161:114535.
PMID: 36931025
The pharmacological inhibition of sodium-glucose cotransporter 2 (SGLT2) has emerged as a treatment for patients with type 2 diabetes mellitus (T2DM), cardiovascular disease and/or other metabolic disturbances, although some of...
6.
Carvalho G, Braz D, Goncalves T, Aires R, Coco L, Guidoni M, et al.
Antioxidants (Basel)
. 2022 Sep;
11(9).
PMID: 36139721
In regions adjacent to the Brazilian Atlantic Forest, Virola oleifera (VO) resin extract has been popularly used for decades as a skin and mucosal healing agent. However, this antioxidant-rich resin...
7.
Matos M, Uriarte E, Seoane N, Picos A, Gil-Longo J, Campos-Toimil M
ChemMedChem
. 2022 Sep;
17(21):e202200476.
PMID: 36109344
Due to the need for new chemical entities for cardiovascular diseases, we have synthesized a new series of nitrate-coumarins and evaluated their vasorelaxant activity in contraction-relaxation studies using rat aorta...
8.
Queiroz S, Ton A, Pereira T, Campagnaro B, Martinelli L, Picos A, et al.
Front Psychiatry
. 2022 Jun;
13:872594.
PMID: 35722583
Alzheimer's disease (AD) is a progressive and incurable neurodegenerative disorder of integrative areas of the brain, characterized by cognitive decline and disability resulting in negative impacts on the family of...
9.
Bandin-Vilar E, Garcia-Quintanilla L, Castro-Balado A, Zarra-Ferro I, Gonzalez-Barcia M, Campos-Toimil M, et al.
Clin Pharmacokinet
. 2022 Jun;
61(6):789-817.
PMID: 35699914
In recent years, many studies on population pharmacokinetics of linezolid have been conducted. This comprehensive review aimed to summarize population pharmacokinetic models of linezolid, by focusing on dosage optimization to...
10.
Aragon-Herrera A, Otero-Santiago M, Anido-Varela L, Morana-Fernandez S, Campos-Toimil M, Garcia-Caballero T, et al.
Front Pharmacol
. 2022 Feb;
13:827033.
PMID: 35185578
The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial evidenced the potential of sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of...